| Literature DB >> 22112295 |
Philip Boyce1, Christine Spratt, Mark Davies, Prue McEvoy.
Abstract
BACKGROUND: Clinical activities that trainees can be trusted to perform with minimal or no supervision have been labelled as Entrustable Professional Activities (EPAs). We sought to examine what activities could be entrusted to psychiatry trainees in their first year of specialist training.Entities:
Mesh:
Year: 2011 PMID: 22112295 PMCID: PMC3295698 DOI: 10.1186/1472-6920-11-96
Source DB: PubMed Journal: BMC Med Educ ISSN: 1472-6920 Impact factor: 2.463
Proportion of participants that rated the activity as mandatory prior to progressing to the next stage of training.
| Activity | Proportion endorsing | |
|---|---|---|
| Antipsychotic | ||
| Antidepressant | ||
| Mood stabilizer | ||
| CBT | 0.23 | |
| Brief psychotherapy | 0.27 | |
| Long-term psychotherapy | 0.13 | |
| Schizophrenia | ||
| Bipolar disorder | ||
| An adjustment disorder | ||
| Crisis admission following self-harm | ||
| Schizophrenia | 0.42 | |
| Bipolar disorder | 0.41 | |
| Depression | 0.41 | |
| Admitting a patient without supervision | 0.56 | |
| Conduct a risk assessment | ||
| Carry out crisis assessment and handover report to duty consultant | ||
| Acute assessment and immediate management of psychiatric emergencies | ||
| Perform appropriate lab investigations to exclude medical complications | ||
| Perform a neurological exam | 0.52 | |
| Formulate a clinical case | ||
| Non-pharmacological management of a patient with personality disorder | 0.19 | |
| Design a biopsychosocial care plan | 0.52 | |
| Complete a discharge summary (without supervision) | ||
| Facilitate a follow-up appointment at a community clinic | 0.58 | |
| Consent a patient for ECT | 0.51 | |
| Perform ECT | 0.31 | |
| Acute sedation of a patient | ||
| Initiate a brief substance misuse intervention | 0.29 | |
| Non-pharmacological management of an anxiety disorder | 0.36 | |
| Pharmacological management of an anxiety disorder | 0.30 | |
Figure 1Responses to question asking whether initiating treatments should be an activity a trainee could be expected to perform by the end of the first stage of training.
'Initiating medication' EPA and the CanMEDS roles.
| Indicative questions | ||
|---|---|---|
| The trainee demonstrates the ability to make an accurate diagnosis, has conducted the appropriate assessments, can describe the evidence for the use of the medication, its dosage, interactions and side effects. | ||
| The trainee shows the ability to explain to the patient the benefits and risks of the medication and how it should be taken and addresses the patients questions. | ||
| The trainee ensures that members of the MDT (and GP) are aware of how the medication fits in with the management plan | ||
| The trainee has obtained informed consent | ||
| The trainee is able to apply the evidence from clinical practice guidelines | ||
| The trainee ensures that the patient is able to access the medication | ||
| Clear and accurate documentation is completed | ||
Initiating medication requires a demonstration of competencies across all the CanMEDS roles. The assessment of the trainee's performance should be conducted in a real life clinical situation under the observation of the supervisor.
Prior to the clinical encounter the trainee should explain to the supervisor the rationale for using this medication, for this patient at this time. This will allow for an assessment of the trainee's knowledge base for the use of this treatment modality.
Figure 2Relationship between an EPA and the underlying competencies.